|
- 积分
- 1334
- 威望
- 1334
- 包包
- 4744
|
实在想做，可以看这里
6 P5 x3 r4 {- U0 d8 ghttp://clinicaltrials.gov/ct2/re ... +cord+AND+stem+cell: l- |" B7 X, ?: h: t4 A' k
Found 57 studies with search of: spinal cord AND stem cell
% @* ^- p- I# A; [$ S; HHide studies that are not seeking new volunteers.
/ t3 B% a! N3 }1 t l8 E+ aHide studies with unknown recruitment status. Display Options Rank Status Study
/ i8 p1 p" S# W( M }0 q1 Recruiting Autologous Bone Marrow Stem Cell Transplantation in Patients With Spinal Cord Injury Condition: Spinal Cord Injury
) u( J& W6 g; w3 i9 a; n8 f$ U( C1 f9 UIntervention: Procedure: Stem Cell Transplantation 4 H: O/ S* P5 S2 l0 F- v
# r c8 K# e$ E- n& T2 Active, not recruiting Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis Condition: Amyotrophic Lateral Sclerosis
- T* ^5 p0 X5 Q& e$ GIntervention: Procedure: surgical implantation
h: z b8 C) J2 ] 0 f0 i c. ^4 n- x- a0 p
3 Recruiting Autologous Stem Cells for Spinal Cord Injury (SCI) in Children Condition: Spinal Cord Injury
- A2 W8 D+ z. R! T9 ]% tIntervention: Biological: bone marrow progenitor cells (BMPC) autologous transplantation + g, V- k4 b2 s. ?; Z; b
. ^8 B7 | t4 Y. U6 g
4 Active, not recruiting Transfer of Bone Marrow Derived Stem Cells for the Treatment of Spinal Cord Injury Condition: Spinal Cord Injury
" l. b5 ]1 w, Q" mIntervention: Biological: autologous mesenchymal stem cells # r/ ]3 q g- x
1 ^+ t0 }" C; B3 Z* R8 q
5 Recruiting Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Patients With Thoracic Spinal Cord Injury Conditions: Spinal Cord Injury Thoracic; Spinal Cord Injury 2 @6 w& e4 p5 {6 N5 x
Intervention: Procedure: HuCNS-SC cells % o, U% w* y" ^+ F0 h# j( j( w+ L
7 v t+ S: m7 }# t# v! D' W- v
6 Completed Safety and Efficacy of Autologous Bone Marrow Stem Cells in Treating Spinal Cord Injury Condition: Spinal Cord Injuries
8 X" T. b& h: v7 O! XInterventions: Procedure: laminectomy; Procedure: Intrathecal
, Y, ?( c. F0 \9 n
: b$ B% _1 q; _% c8 L" a7 Completed Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors Conditions: Brain and Central Nervous System Tumors; Neuroblastoma; Sarcoma
9 b" I, \% Z) z& c3 n, \+ i3 v1 PInterventions: Biological: filgrastim; Drug: carboplatin; Drug: cisplatin; Drug: cyclophosphamide; Drug: etoposide; Drug: thiotepa; Drug: vincristine sulfate; Procedure: conventional surgery; Procedure: peripheral blood stem cell transplantation
) b( f5 z# d/ G7 h* e' e 7 l5 R7 Q) i- ]& L* {' M& X+ l
8 Completed Autologous Adipose Derived MSCs Transplantation in Patient With Spinal Cord Injury. Condition: Spinal Cord Injury
5 S4 D' o- Z' z2 C: R+ YIntervention: Other: Autologous Adipose Derived Mesenchymal Stem Cells
6 `2 W0 w5 i$ \( ~ g0 i 3 O5 @) m: X; |9 c x( J- f: ?
9 Recruiting Bone Graft Materials Observational Registry Conditions: Degenerative Disc Disease; Herniated Disc; Spinal Stenosis; Spondylolithesis; Spinal Deformity; Cervical Myelopathy; Failed Back Surgery Syndrome; Spinal Cord Neoplasms
$ F! H+ h. K- Q! JIntervention: Device: Bone growth substitute, autograft or allograft 4 c" I* f4 ?& b% k' j- V4 U0 g S
# o: q0 K% ?7 Q% F7 V6 W+ J10 Recruiting Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Autoimmune Neurologic Disease That Did Not Respond to Previous Therapy Condition: Autoimmune Disorder , [$ _$ P* b( `
Interventions: Biological: anti-thymocyte globulin; Drug: carmustine; Drug: cytarabine; Drug: etoposide; Drug: melphalan; Drug: prednisone; Procedure: autologous hematopoietic stem cell transplantation; Procedure: peripheral blood stem cell transplantation; Procedure: syngeneic bone marrow transplantation; Other: laboratory biomarker analysis
" h( ]6 r- J$ z5 c8 o
0 b8 N& X+ m' m5 T11 Active, not recruiting Hematopoietic Stem Cell Therapy for Patients With Multiple Sclerosis Condition: Multiple Sclerosis
. q$ E! j. s4 WIntervention: Procedure: hematopoietic stem cell transplantation 5 {( j* Z# E7 g! P. G% O9 z7 r+ |. {
1 Y, d6 |/ L2 }1 b# B12 Recruiting Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica Condition: Neuromyelitis Optica (NMO) & h0 B w! ~% `# M2 E
Intervention: Procedure: AHSCT
5 H) N) S" @: L$ K
+ y/ H: b* S" {9 F8 v- `1 n* c( m13 Active, not recruiting High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study Condition: Multiple Sclerosis 0 o2 w8 F& i! y
Interventions: Drug: Granulocyte-colony stimulating factor (G-CSF) and prednisone; Drug: Carmustine, etoposide, cytarabine, and melphalan (BEAM); Procedure: Autologous hematopoietic stem cell transplant : o; Z4 z x( o& E. W
& n n4 q6 J" M+ R9 ^
14 Completed Cell Transplant in Spinal Cord Injury Patients Condition: Chronic Spinal Cord Injury 2 B3 ]* \+ v! w3 w' q1 \
Interventions: Procedure: Autologous bone marrow transplant; Procedure: Physical therapy " k1 Q6 U4 Q3 z$ j* a+ o
( q: u& Y1 X7 p15 Active, not recruiting Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic
# X4 m' p1 M: q3 [7 tInterventions: Drug: fludarabine phosphate; Drug: cyclophosphamide; Biological: Rituxan (rituximab); Biological: filgrastim; Drug: methylprednisolone; Other: immunologic technique; Other: laboratory biomarker analysis; Procedure: autologous hematopoietic stem cell transplantation , ?. U) ]- W5 s* V* I% W
2 ^$ _8 Y# G* ~& a; l1 `, j& R16 Unknown † Mesenchymal Stem Cells for the Treatment of MS Condition: Multiple Sclerosis 9 ^0 ?; L2 d" Z+ k- S
Intervention: Biological: injection of autologous stem cells . q* t" b0 T5 g" R
i' j7 k( [& k/ W8 M/ g
17 Recruiting Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma Condition: Lymphoma 1 T! w- ~7 q- c
Interventions: Drug: carmustine; Drug: cyclophosphamide; Drug: etoposide; Procedure: peripheral blood stem cell transplantation; Radiation: radiation therapy; Biological: G-CSF 0 \- Z* I/ B9 v2 i' x
6 b& Z/ t$ e) t7 n/ s& D6 F2 x# F9 b
18 Recruiting Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma Condition: Sarcoma
. z- `7 l6 A- e# L# l* L2 ~; aInterventions: Biological: dactinomycin; Drug: busulfan; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: ifosfamide; Drug: melphalan; Drug: vincristine sulfate; Procedure: autologous hematopoietic stem cell transplantation; Procedure: conventional surgery; Radiation: radiation therapy ' e3 o( Z" S1 F- \+ h/ t
# `1 V& k' l: R19 Recruiting Clinical Trial on The Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis (Extension CMN/ELA) Condition: Amyotrophic Lateral Sclerosis
' K2 z) r. Z: IInterventions: Procedure: Laminectomy and bone marrow stem cells transplantation; Procedure: Intrathecal infusion of autologous bone marrow stem cells; Procedure: Intrathecal infusion of placebo (saline solution).
0 \* G4 x' S- U# Y% X $ h, P% X) N) M
20 Active, not recruiting Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma Condition: Neuroblastoma " t n4 f! C8 E9 ^8 P. A
Interventions: Drug: Cisplatin and Etoposide; Drug: Adriamycin and Cyclophosphamide
x/ x3 D8 V0 y3 _. |2 T: y+ s " H, x) w: a8 J1 S
Found 57 studies with search of: spinal cord AND stem cell
8 J' M9 r" U% `Hide studies that are not seeking new volunteers.8 S* X; `1 L* s6 F8 F& [, G' P
Hide studies with unknown recruitment status. Display Options Rank Status Study
z7 `% m' ^7 g. K- @) M21 Completed Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis Condition: Amyotrophic Lateral Sclerosis
" j% W, B3 g0 q$ m1 ?( XInterventions: Procedure: Laminectomy and bone marrow stem cells transplantation; Procedure: Autologous bone marrow cells collection
; p0 F/ @3 y( i- j
) f% ?* h! |0 ~. a) |6 \22 Active, not recruiting Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS) Condition: Amyotrophic Lateral Sclerosis * Z& P; D) Y7 Y% @
Intervention: Biological: autologous mesenchymal stem cells L. p4 b1 F* s; g% h( H( x
, d2 h: [" J: o: |" v% j2 }4 \" D
23 Active, not recruiting Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis Condition: Amyotrophic Lateral Sclerosis - h4 e# z) W( r* }5 l( S' R: |* H
Intervention: Biological: autologous bone marrow-derived stem cells U9 X+ N* i0 `) ~+ X
* E: [" w. M' w7 u/ Z" l
24 Unknown † Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical Response Condition: Amyotrophic Lateral Sclerosis
; x4 v; {4 S8 k: yIntervention: Drug: Cistanche Total Glycosides ! D5 r+ l) T1 \* W' T' G
# P$ O$ T7 N6 B' i1 h0 d25 Completed G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response Condition: Amyotrophic Lateral Sclerosis 3 R+ C% H1 l& R8 s+ Z& _
Interventions: Drug: Granulocyte Colony Stimulating Factor; Drug: NS / A! e- Z* z/ u& {
; Y# x U8 v L! A( E! P26 Active, not recruiting Derivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic Cells Condition: Amyotrophic Lateral Sclerosis
1 |$ g0 v% `! j _0 J$ r4 xIntervention:
/ Z, K) k+ ?! X8 v6 x* U9 d, P
3 w& r0 S4 o! p. x$ a27 Not yet recruiting Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients. Condition: Amyotrophic Lateral Sclerosis
0 C& w9 y$ Z @" N, I& {4 g* ]8 I% OInterventions: Biological: MSC-NTF cells transplantation (i.m.); Biological: MSC-NTF cells transplantation (i.t.) 5 x1 i. x% z/ {- n/ p( i: F
6 J- i; x5 o, O% G# Y$ E1 |, B# `
28 Active, not recruiting Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS) Condition: Amyotrophic Lateral Sclerosis 2 F1 x4 M1 G. l, Y. i+ t) N/ u |
Intervention: Drug: SB-509
* U8 Q5 s- X4 j
1 h- L' q- ?+ o7 M! @29 Active, not recruiting Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Conditions: Brain and Central Nervous System Tumors; Extra-adrenal Paraganglioma ! d7 `. K- e5 A
Interventions: Drug: temozolomide; Drug: vorinostat; Genetic: DNA methylation analysis; Genetic: western blotting; Other: laboratory biomarker analysis; Other: pharmacological study
6 [0 z# A+ L4 {: G- P5 a4 h ; g3 F- D" D0 |1 L2 M0 e9 ?+ ~" N
30 Active, not recruiting Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors Conditions: Brain and Central Nervous System Tumors; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific # I8 K& o% R! S/ N/ g* z
Interventions: Drug: carboplatin; Drug: tamoxifen citrate; Drug: topotecan hydrochloride; Other: pharmacological study
5 t7 l C; Y9 _ v4 e
: u# M) W* I d+ n31 Recruiting Efficacy and Safety of Umbilical Cord Blood Injection for Critical Limb Ischemia Condition: Critical Limb Ischemia ( t( w2 Y8 ], B# K; J- N$ \! O9 z' k
Intervention: Biological: Cord blood stem cell injection - K7 Z1 [ D; b
& p u' L! y1 N5 L0 u
|
|
发表于 2011-5-21 11:11
。。。。可否提供中文的信息，谢谢。
我看看先，看看有没有可行性的方案。